Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharma Mar Sa (PHMMF)

Pharma Mar Sa (PHMMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 483,569
  • Shares Outstanding, K 18,010
  • Annual Sales, $ 171,150 K
  • Annual Income, $ 1,230 K
  • 60-Month Beta 0.20
  • Price/Sales 3.10
  • Price/Cash Flow 8.30
  • Price/Book 2.15
Trade PHMMF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/22/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.8500 unch
on 04/15/24
29.2900 -8.33%
on 03/25/24
-3.5280 (-11.61%)
since 03/15/24
3-Month
26.8500 unch
on 04/15/24
44.1300 -39.16%
on 01/24/24
-16.4344 (-37.97%)
since 01/11/24
52-Week
26.8500 unch
on 04/15/24
46.2600 -41.96%
on 12/13/23
-18.5400 (-40.85%)
since 04/11/23

Business Summary

Pharma Mar SA is a biopharmaceutical company. It engaged in the discovery and development of marine-derived anticancer drugs. The company's product pipeline consists of PM1183, plitidepsin, and PM184 which are in clinical trial stage. It operates primarily in Germany, Italy, France, Switzerland, United...

See More

Key Turning Points

3rd Resistance Point 26.8500
2nd Resistance Point 26.8500
1st Resistance Point 26.8500
Last Price 26.8500
1st Support Level 26.8500
2nd Support Level 26.8500
3rd Support Level 26.8500

See More

52-Week High 46.2600
Fibonacci 61.8% 38.8454
Fibonacci 50% 36.5550
Fibonacci 38.2% 34.2646
Last Price 26.8500
52-Week Low 26.8500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar